Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2013, Article ID 498581, 4 pages
http://dx.doi.org/10.1155/2013/498581
Clinical Study

Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood

1Department of Pediatric, Istanbul Training and Research Hospital, Istanbul, Turkey
2Department of Biochemistry, Istanbul Training and Research Hospital, 34080 Istanbul, Turkey
3Department of Pediatric, Mustafa Kemal University Medical Faculty, 31000 Antakya, Turkey
4Department of Biochemistry, Giresun University Medical Faculty, 28000 Giresun, Turkey
5Department of Pediatric Rheumatology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey

Received 26 March 2013; Revised 16 June 2013; Accepted 7 August 2013

Academic Editor: Luis R. Espinoza

Copyright © 2013 Hatice Onur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Tunca, S. Akar, F. Onen et al., “Familial Mediterranean Fever (FMF) in Turkey: results of a nationwide multicenter study,” Medicine, vol. 84, no. 1, pp. 1–11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Arıca, C. Ozer, V. Arıca, A. Karakuş, T. Celik, and R. Güneşaçar, “Evaluation of the mean platelet volume in children with familial Mediterranean fever,” Rheumatology International, vol. 32, no. 11, pp. 3559–3563, 2012. View at Publisher · View at Google Scholar
  3. I. Ben-Zvi and A. Livneh, “Chronic inflammation in FMF: markers, risk factors, outcomes and therapy,” Nature Reviews Rheumatology, vol. 7, no. 2, pp. 105–112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. J. M. Pruijn, E. R. Vossenaar, J. W. Drijfhout, W. J. van Venrooij, and A. J. W. Zendman, “Anti-CCP antibody detection facilitates early diagnosis and prognosis of rheumatoid arthritis,” Current Rheumatology Reviews, vol. 1, pp. 11–71, 2005. View at Google Scholar
  5. T. B. Niewold, M. J. Harrison, and S. A. Paget, “Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis,” QJM, vol. 100, no. 4, pp. 193–201, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. W. J. van Venrooij, J. M. Hazes, and H. Visser, “Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis,” Netherlands Journal of Medicine, vol. 60, no. 10, pp. 383–388, 2002. View at Google Scholar · View at Scopus
  7. K. Stankovic and G. Grateau, “Auto inflammatory syndromes: diagnosis and treatment,” Joint Bone Spine, vol. 74, no. 6, pp. 544–550, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Arısoy, Ö. Kasapçopur, R. Kodakoğlu et al., “Articular involvement in childhood familial Mediterranean fever,” Clinical and Experimental Rheumatology, vol. 18, no. D6, p. 289, 2000. View at Google Scholar
  9. F. Yalçinkaya, S. Ozen, Z. B. Ozçakar et al., “A new set of criteria for the diagnosis of familial Mediterranean fever in childhood,” Rheumatology, vol. 48, no. 4, pp. 395–398, 2009. View at Publisher · View at Google Scholar
  10. E. Guler, E. Kaptanoglu, O. Sahin, F. Candan, E. Hayta, and H. Elden, “Autoantibodies are not associated with familial mediterranean fever,” Acta Reumatológica Portuguesa, vol. 37, no. 2, pp. 144–148, 2012. View at Google Scholar
  11. S. Karatay, K. Yildirim, A. Erdal, H. Uzkeser, F. H. Erdem, and V. Yanmaz, “Anti-cyclic citrullinated peptide antibodies are not associated with familial mediterranean fever,” Journal of Back and Musculoskeletal Rehabilitation, vol. 23, no. 1, pp. 21–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Ceri, S. Unverdi, M. Altay et al., “Anti-cyclic citrullinated peptides positivity rate in patients with familial Mediterranean fever,” Clinical and Experimental Rheumatology, vol. 28, no. 4, supplement 60, pp. S58–S61, 2010. View at Google Scholar
  13. A. Uyanik, F. Albayrak, M. H. Uyanik, H. Dursun, M. Keles, and R. Cetinkaya, “Antibodies directed to cyclic citrullinated peptides in familial Mediterranean fever,” Rheumatology International, vol. 30, no. 4, pp. 467–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. P. Riedemann, S. Muñoz, and A. Kavanaugh, “The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis—a systematic review,” Clinical and Experimental Rheumatology, vol. 23, no. 5, pp. S69–S76, 2005. View at Google Scholar · View at Scopus
  15. R. Goldbach-Mansky, J. Lee, A. McCoy et al., “Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset,” Arthritis Research, vol. 2, no. 3, pp. 236–243, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Bizzaro, G. Mazzanti, E. Tonutti, D. Villalta, and R. Tozzoli, “Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis,” Clinical Chemistry, vol. 47, no. 6, pp. 1089–1093, 2001. View at Google Scholar · View at Scopus
  17. E. Berglin, L. Padyukov, U. Sundin et al., “A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis,” Arthritis Research & Therapy, vol. 6, no. 4, pp. R303–R308, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. W. Choi, M. K. Lim, D. H. Shin, J. J. Park, and S. C. Shim, “Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis,” Journal of Korean Medical Science, vol. 20, no. 3, pp. 473–478, 2005. View at Google Scholar · View at Scopus
  19. Ö. Kasapçopur, S. Altun, M. Aslan et al., “Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis,” Annals of the Rheumatic Diseases, vol. 63, no. 12, pp. 1687–1689, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Omar, I. Abo-Elyoun, H. Hussein et al., “Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial),” Joint Bone Spine, vol. 80, no. 1, pp. 38–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. K. H. Brunner and F. C. Sitzmann, “The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with juvenile idiopathic arthritis,” Clinical and Experimental Rheumatology, vol. 24, no. 4, pp. 449–451, 2006. View at Google Scholar · View at Scopus
  22. M. van Rossum, R. van Soesbergen, S. de Kort et al., “Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis,” Journal of Rheumatology, vol. 30, no. 4, pp. 825–828, 2003. View at Google Scholar · View at Scopus
  23. R. Gupta, M. M. Thabah, B. Vaidya, S. Gupta, R. Lodha, and S. K. Kabra, “Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis,” Indian Journal of Pediatrics, vol. 77, no. 1, pp. 41–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. K. Kim, J. Bae, H. Lee, J. H. Kim, S. H. Park, and J. Y. Choe, “Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritisaffected families,” The Korean Journal of Internal Medicine, vol. 28, no. 1, pp. 45–53, 2013. View at Publisher · View at Google Scholar